title: PVR recurrence and the timing of silicon oil removal.
abstract: BACKGROUND
  Following vitrectomy for PVR-associated retinal detachment, placement of an encircling band, filling with silicone oil (SO) and successful retinal reattachment, a recurrence of PVR can develop. Retinal redetachment after SO removal is usually due to secondary or residual PVR. We wanted to ascertain whether the anatomical and functional outcomes of surgery in patients with a reattached retina and recurrent PVR can be improved by delaying the removal of SO.
  
  
  METHODS
  112 consecutive patients with PVR-associated retinal detachment who had undergone vitrectomy with SO filling, were monitored for at least 6 months after SO removal. Prior to SO removal, the retina posterior to the encircling band had to be completely reattached. Patients who developed PVR after SO filling were divided into two groups according to the duration of SO retention: 12 - 18 months (group 2: n = 48); > 18 months (group 3: n = 21). Individuals without PVR recurrence after SO filling and in whom the SO was consequently removed within 4 - 12 months served as control (group 1: n = 43). Anatomical success, intraocular pressure (IOP) and best-corrected visual acuity (BCVA) served as the primary clinical outcome parameters.
  
  
  RESULTS
  Six months after SO removal, the anatomical success rates (86.3 %, 88.8 % and 84.6 %, in groups 1, 2 and 3, respectively; log rank = 0.794) and the BCVAs (p = 0.861) were comparable in the three groups. Mean IOP (p = 0.766), and the frequency of complications such as PVR recurrence (p = 0.936), bullous keratopathy (p = 0.981) and macular pucker (p = 0.943) were likewise similar. Patients in whom SO was retained for more than 18 months had the highest IOPs and required the heaviest dosage with anti-glaucoma drugs.
  
  
  CONCLUSIONS
  In patients who develop a recurrence of PVR after vitrectomy and SO filling the surgeon can observe and treat retinal changes for up to 18 months without impairing the anatomical and functional outcomes. The retention of SO for more than 18 months does not improve the anatomical outcome. However, it can impair the functional outcome by precipitating the development of a persisting secondary glaucoma.
authors.affiliation: Department of Ophthalmology, University of Bern, Inselspital, Bern, Switzerland. markus.halberstadt@insel.ch
authors.forename: M
authors.initials: M
authors.lastname: Halberstadt
authors.forename: D
authors.initials: D
authors.lastname: Domig
authors.forename: L
authors.initials: L
authors.lastname: Kodjikian
authors.forename: F
authors.initials: F
authors.lastname: Koerner
authors.forename: J G
authors.initials: JG
authors.lastname: Garweg
mesh_terms: D015897:Comorbidity; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000453:epidemiology* / Q000628:therapy*; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention; D012827:Silicone Oils / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome; D018630:Vitreoretinopathy, Proliferative / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D012827:Silicone Oils